Jackie Kent

See the following -

TransCelerate Selects Cognizant To Develop A Clinical Trials Collaboration Platform

Press Release | TransCelerate BioPharma Inc., Cognizant | July 24, 2014

Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials...

Read More »